Market Landscape: Anti-Rejection Drugs

Brief:

Market landscape exploration into the likely adoption of a new anti-rejection drug for the treatment of organ transplant patients

Countries:

US

Methodology:

Qualitative and quantitative: transplant surgeons, transplant nurses; nephrologists

The research explored:

• The prescribing legacy and potential for different routes of administration and regimens

• The motivations for prescribing choices

• The white space needed for the new product

Delivered:

Detailed mapping of the competitive landscape, highlighting potential drivers and barriers to adoption of different current treatments allowing for the next stage of positioning and messaging development to ensure a successful communication strategy ready for launch